TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways

Experimental Cell Research

Volumn 314, Issue 3, 2008, Pages 509-529

  Rivas, Martín A ^a   Carnevale, Romina P ^a   Proietti, Cecilia J ^a   Rosemblit, Cinthia ^a   Beguelin, Wendy ^a   Salatino, Mariana ^a   Charreau, Eduardo H ^a   Frahm, Isabel ^b   Sapia, Sandra ^c   Brouckaert, Peter ^d   Elizalde, Patricia V ^a   Schillaci, Roxana ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Sanatorio Mater Dei   (Argentina)

^c Fundacion para Combatir La Leucemia   (Argentina)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Breast cancer; NF B; TNF ; TNF receptors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

MURINAE;

EID: 38349043768     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.10.005     Document Type: Article

References (58)

1. Wu S., Boyer C.M., Whitaker R.S., Berchuck A., Wiener J.R., Weinberg J.B., and Bast Jr. R.C. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression. Cancer Res. 53 (1993) 1939-1944
2. Rothe J., Gehr G., Loetscher H., and Lesslauer W. Tumor necrosis factor receptors - structure and function. Immunol. Res. 11 (1992) 81-90
3. Liu Z.G., Hsu H., Goeddel D.V., and Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87 (1996) 565-576
4. Rothe M., Wong S.C., Henzel W.J., and Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78 (1994) 681-692
5. Yang J., Lin Y., Guo Z., Cheng J., Huang J., Deng L., Liao W., Chen Z., Liu Z., and Su B. The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat. Immunol. 2 (2001) 620-624
6. Hsu H., Xiong J., and Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81 (1995) 495-504
7. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., and Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401 (1999) 82-85
8. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
9. Pomerantz J.L., and Baltimore D. Two pathways to NF-kappaB. Mol. Cell 10 (2002) 693-695
10. Lee P.P., Hwang J.J., Murphy G., and Ip M.M. Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells. Endocrinology 141 (2000) 3764-3773
11. Varela L.M., and Ip M.M. Tumor necrosis factor-alpha: a multifunctional regulator of mammary gland development. Endocrinology 137 (1996) 4915-4924
12. Suganuma M., Okabe S., Marino M.W., Sakai A., Sueoka E., and Fujiki H. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res. 59 (1999) 4516-4518
13. Burow M.E., Weldon C.B., Tang Y., Navar G.L., Krajewski S., Reed J.C., Hammond T.G., Clejan S., and Beckman B.S. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res. 58 (1998) 4940-4946
14. Zhou B.P., Hu M.C., Miller S.A., Yu Z., Xia W., Lin S.Y., and Hung M.C. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J. Biol. Chem. 275 (2000) 8027-8031
15. Weldon C.B., Parker A.P., Patten D., Elliott S., Tang Y., Frigo D.E., Dugan C.M., Coakley E.L., Butler N.N., Clayton J.L., Alam J., Curiel T.J., Beckman B.S., Jaffe B.M., and Burow M.E. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Int. J. Oncol. 24 (2004) 1473-1480
16. Varela L.M., Stangle-Castor N.C., Shoemaker S.F., Shea-Eaton W.K., and Ip M.M. TNFalpha induces NFkappaB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. J. Cell. Physiol. 188 (2001) 120-131
17. Pirianov G., and Colston K.W. Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis. Mol. Cell. Endocrinol. 172 (2001) 69-78
18. Salatino M., Schillaci R., Proietti C.J., Carnevale R., Frahm I., Molinolo A.A., Iribarren A., Charreau E.H., and Elizalde P.V. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Oncogene 23 (2004) 5161-5174
19. Proietti C., Salatino M., Rosemblit C., Carnevale R., Pecci A., Kornblihtt A.R., Molinolo A.A., Frahm I., Charreau E.H., Schillaci R., and Elizalde P.V. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol. Cell. Biol. 25 (2005) 4826-4840
20. Lanari C., Molinolo A.A., and Pasqualini C.D. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. Cancer Lett. 33 (1986) 215-223
21. Salatino M., Labriola L., Schillaci R., Charreau E.H., and Elizalde P.V. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Exp. Cell Res. 265 (2001) 152-166
22. Mathiasen I.S., Hansen C.M., Foghsgaard L., and Jaattela M. Sensitization to TNF-induced apoptosis by 1,25-dihydroxy vitamin D(3) involves up-regulation of the TNF receptor 1 and cathepsin B. Int. J. Cancer 93 (2001) 224-231
23. Ameloot P., Fiers W., De Bleser P., Ware C.F., Vandenabeele P., and Brouckaert P. Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants. J. Biol. Chem. 276 (2001) 37426-37430
24. Dentener M.A., Smit F.T., Francot G.J., and Buurman W.A. Characterization of two monoclonal antibodies directed against bactericidal/permeability-increasing protein. J. Infect. Dis. 170 (1994) 1483-1489
25. Dran G., Luthy I.A., Molinolo A.A., Montecchia F., Charreau E.H., Pasqualini C.D., and Lanari C. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma. Breast Cancer Res. Treat. 35 (1995) 173-186
26. van der P.T., Coyle S.M., Levi M., Jansen P.M., Dentener M., Barbosa K., Buurman W.A., Hack C.E., ten Cate J.W., Agosti J.M., and Lowry S.F. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 89 (1997) 3727-3734
27. Sheehan K.C., Pinckard J.K., Arthur C.D., Dehner L.P., Goeddel D.V., and Schreiber R.D. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75. J. Exp. Med. 181 (1995) 607-617
28. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., and Gerritsen M.E. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272 (1997) 21096-21103
29. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 (2002) 221-227
30. Rubio M.F., Werbajh S., Cafferata E.G., Quaglino A., Colo G.P., Nojek I.M., Kordon E.C., Nahmod V.E., and Costas M.A. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25 (2006) 1367-1377
31. Kalb A., Bluethmann H., Moore M.W., and Lesslauer W. Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J. Biol. Chem. 271 (1996) 28097-28104
32. Mukhopadhyay A., Suttles J., Stout R.D., and Aggarwal B.B. Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 276 (2001) 31906-31912
33. Kaiser G.C., Yan F., and Polk D.B. Conversion of TNF alpha from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase. Exp. Cell Res. 249 (1999) 349-358
34. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., and Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature 414 (2001) 313-317
35. Jupp O.J., McFarlane S.M., Anderson H.M., Littlejohn A.F., Mohamed A.A., MacKay R.H., Vandenabeele P., and MacEwan D.J. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem. J. 359 (2001) 525-535
36. Tang F., Tang G., Xiang J., Dai Q., Rosner M.R., and Lin A. The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol. Cell. Biol. 22 (2002) 8571-8579
37. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., and Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385 (1997) 544-548
38. Condorelli G., Morisco C., Latronico M.V., Claudio P.P., Dent P., Tsichlis P., Condorelli G., Frati G., Drusco A., Croce C.M., and Napoli C. TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J. 16 (2002) 1732-1737
39. Park S.J., Kim Y.Y., Ju J.W., Han B.G., Park S.I., and Park B.J. Alternative splicing variants of c-FLIP transduce the differential signal through the Raf or TRAF2 in TNF-induced cell proliferation. Biochem. Biophys. Res. Commun. 289 (2001) 1205-1210
40. Park Y.C., Ye H., Hsia C., Segal D., Rich R.L., Liou H.C., Myszka D.G., and Wu H. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 101 (2000) 777-787
41. Tartaglia L.A., Pennica D., and Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268 (1993) 18542-18548
42. Garcia-Tunon I., Ricote M., Ruiz A., Fraile B., Paniagua R., and Royuela M. Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative). Cancer Sci. 97 (2006) 1044-1049
43. Basseres D.S., and Baldwin A.S. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25 (2006) 6817-6830
44. McFarlane S.M., Pashmi G., Connell M.C., Littlejohn A.F., Tucker S.J., Vandenabeele P., and MacEwan D.J. Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly. FEBS Lett. 515 (2002) 119-126
45. Chainy G.B., Singh S., Raju U., and Aggarwal B.B. Differential activation of the nuclear factor-kappa B by TNF muteins specific for the p60 and p80 TNF receptors. J. Immunol. 157 (1996) 2410-2417
46. Haridas V., Darnay B.G., Natarajan K., Heller R., and Aggarwal B.B. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J. Immunol. 160 (1998) 3152-3162
47. de Haij S., Bakker A.C., van der Geest R.N., Haegeman G., Vanden Berghe W., Aarbiou J., Daha M.R., and van Kooten C. NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase. J. Am. Soc. Nephrol. 16 (2005) 1603-1611
48. Lin F.S., Lin C.C., Chien C.S., Luo S.F., and Yang C.M. Involvement of p42/p44 MAPK, JNK, and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells. J. Cell Physiol 202 (2005) 464-473
49. Madrid L.V., Mayo M.W., Reuther J.Y., and Baldwin Jr. A.S. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276 (2001) 18934-18940
50. Sizemore N., Lerner N., Dombrowski N., Sakurai H., and Stark G.R. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J. Biol. Chem. 277 (2002) 3863-3869
51. Yu Q., Geng Y., and Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 411 (2001) 1017-1021
52. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., and Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19 (1999) 2690-2698
53. Scott K.A., Moore R.J., Arnott C.H., East N., Thompson R.G., Scallon B.J., Shealy D.J., and Balkwill F.R. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol. Cancer Ther. 2 (2003) 445-451
54. Clarke C.L., and Sutherland R.L. Progestin regulation of cellular proliferation. Endocr. Rev. 11 (1990) 266-301
55. Luo J.L., Maeda S., Hsu L.C., Yagita H., and Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cells 6 (2004) 297-305
56. Park B.K., Zhang H., Zeng Q., Dai J., Keller E.T., Giordano T., Gu K., Shah V., Pei L., Zarbo R.J., McCauley L., Shi S., Chen S., and Wang C.Y. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat. Med. 13 (2007) 62-69
57. Matsumoto G., Namekawa J., Muta M., Nakamura T., Bando H., Tohyama K., Toi M., and Umezawa K. Targeting of nuclear factor kappaB pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Clin. Cancer Res. 11 (2005) 1287-1293
58. Biswas D.K., Shi Q., Baily S., Strickland I., Ghosh S., Pardee A.B., and Iglehart J.D. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. U. S. A 101 (2004) 10137-10142